Published by Josh White on 19th August 2019
(Sharecast News) - Drug discovery and development company Redx Pharma has successfully completed dosing of the first cohort of patients in its ongoing phase 1 and 2 study with 'RXC004', it announced on Monday.
URL: http://www.digitallook.com/dl/news/story/29454665/...